SCHEMBL2427404

SCHEMBL2427404

Cc1nc(C(F)(F)F)c(C(=O)Nc2ncncc2-c2ccc(Cl)c(Cl)c2)s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NTRK1 P04629 1/20 0.44
▸ ABL1 P00519 3/20 0.41
▸ MAPT P10636 4/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ GAA P10253 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ WDR5 P61964 1/20 0.36
▸ CHUK O15111 1/20 0.36
▸ USP7 Q93009 1/20 0.36
▸ ATF1 P18846 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ EIF4E P06730 1/20 0.35
▸ CLK1 P49759 1/20 0.35
▸ CLK2 P49760 1/20 0.35
▸ DYRK1A Q13627 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL557468 0.81 MAPT (0.45) NTRK1MAPTALDH1A1GAAKDM4E
SCHEMBL2202643 0.79 CHRM3 (0.44) MAPTALDH1A1GAAKDM4EHTT
SCHEMBL12424048 0.78 MEN1 (0.43) ABL1MAPTALDH1A1GAAKDM4E
SCHEMBL13805345 0.77 LMNA (0.52) NTRK1ABL1GAAWDR5CLK1
SCHEMBL10213156 0.77 KMT2A (0.56) MAPTALDH1A1GAAKDM4EHTT
SCHEMBL12323248 0.75 CYP3A4 (0.44) ABL1ALDH1A1GAAKDM4ETDP1
SCHEMBL14564442 0.74 MAPT (0.44) MAPTALDH1A1GAAKDM4EHTT
SCHEMBL14564410 0.74 MAPT (0.44) MAPTALDH1A1GAAKDM4EHTT
SCHEMBL14507132 0.74 MAPT (0.49) ABL1MAPTALDH1A1HTTSMN1; SMN2
SCHEMBL14564506 0.73 MAPT (0.43) MAPTALDH1A1GAAKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966161-B1 CARBOXAMIDES FOR CONTROLLING UNDESIRED MICRO-ORGANISMS IN PLANT PROTECTION BAYER CROPSCIENCE AG (DE) 2011-09-28 — — EP disclosed
US-20090163516-A1 CARBOXAMIDES FOR CONTROLLING UNDESIRED MICRO-ORGANISMS IN PLANT PROTECTION BAYER CROPSCIENCE AG (DE) 2009-06-25 — — US disclosed
US-20090163516-A1 CARBOXAMIDES FOR CONTROLLING UNDESIRED MICRO-ORGANISMS IN PLANT PROTECTION BAYER CROPSCIENCE AG (DE) 2009-06-25 — — US disclosed
US-20090163516-A1 CARBOXAMIDES FOR CONTROLLING UNDESIRED MICRO-ORGANISMS IN PLANT PROTECTION BAYER CROPSCIENCE AG (DE) 2009-06-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163516-A1 CARBOXAMIDES FOR CONTROLLING UNDESIRED MICRO-ORGANISMS IN PLANT PROTECTION CAT, MGAM, PGLS NTRK1 4541/4885ABL1 2745/4885MAPT 3079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback